Surendralal Lanca Karsanbhai - 03 Nov 2025 Form 4 Insider Report for EMERSON ELECTRIC CO (EMR)

Role
President & CEO, Director
Signature
/s/ John A.. Sperino, Attorney-in-Fact for Surendralal Lanca Karsanbhai
Issuer symbol
EMR
Transactions as of
03 Nov 2025
Transactions value $
-$10,049,627
Form type
4
Filing time
05 Nov 2025, 16:23:42 UTC
Previous filing
03 Jun 2025
Next filing
06 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Karsanbhai Surendralal Lanca President & CEO, Director C/O EMERSON ELECTRIC CO., 8027 FORSYTH BLVD., ST. LOUIS /s/ John A.. Sperino, Attorney-in-Fact for Surendralal Lanca Karsanbhai 05 Nov 2025 0001754881

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EMR Common Stock Award +164K +89.93% 346K 03 Nov 2025 Direct F1, F2
transaction EMR Common Stock Tax liability -$10M -72.1K -20.86% $139.46 273K 03 Nov 2025 Direct F3, F4
transaction EMR Common Stock Award +54.5K +19.92% 328K 03 Nov 2025 Direct F5, F6
holding EMR Common Stock 453 03 Nov 2025 Custodian Account for Daughter
holding EMR Common Stock 453 03 Nov 2025 Custodian Account for Son
holding EMR Common Stock 165K 03 Nov 2025 By Trust
holding EMR Common Stock 49.4 03 Nov 2025 401(k) excess plan
holding EMR Common Stock 2.49K 03 Nov 2025 401(k) excess plan II
holding EMR Common Stock 661 03 Nov 2025 401(k) plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquisition of shares pursuant to Rile 16b-3 upon payout of 163,588 earned units under a performance share award under a shareholder-approved benefit plan. The payout was based on the level of achievement of financial targets for the performance period ended September 30, 2025.
F2 Price is not applicable to the acquisition described in Note 1.
F3 Shares withheld for required minimum taxes upon vesting of units under a performance share award described in Note 1.
F4 Fair market value on date of withholding described in Note 1.
F5 Grant to Reporting Person of 54,475 restricted stock units under shareholder approved benefit plan pursuance to Rule 16b-3(d).
F6 Price is not applicable to acquisitions resulting from grants of restricted stock units.